These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 16380836)

  • 21. [LY231514. A multitargeted antifolate (MTA)].
    Lansiaux A; Degardin M; Bailly C
    Bull Cancer; 1999 Sep; 86(9):727-31. PubMed ID: 10519965
    [No Abstract]   [Full Text] [Related]  

  • 22. Pemetrexed in the treatment of selected solid tumors.
    Adjei AA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):50-3. PubMed ID: 12023793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pemetrexed, a multitargeted antifolate drug, demonstrates lower efficacy in comparison to methotrexate against osteosarcoma cell lines.
    Bodmer N; Walters DK; Fuchs B
    Pediatr Blood Cancer; 2008 Apr; 50(4):905-8. PubMed ID: 17534933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemetrexed disodium.
    Gibbs D; Jackman A
    Nat Rev Drug Discov; 2005 May; Suppl():S16-7. PubMed ID: 15962527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemetrexed: single-agent and combination phase I study overview.
    Boyer MJ; Rivory LP; Clarke SJ
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):18-23. PubMed ID: 12571806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced receptor-mediated endocytosis and cytotoxicity of a folic acid-desacetylvinblastine monohydrazide conjugate in a pemetrexed-resistant cell line lacking folate-specific facilitative carriers but with increased folate receptor expression.
    Zhao R; Diop-Bove N; Goldman ID
    Mol Pharmacol; 2014 Feb; 85(2):310-21. PubMed ID: 24249723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future directions in the development of pemetrexed.
    Calvert H; Bunn PA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):54-61. PubMed ID: 12023794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemetrexed disodium (Eli Lilly).
    Norman P
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1611-22. PubMed ID: 11763166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pemetrexed for diffuse malignant pleural mesothelioma.
    Manegold C; Aisner J
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):30-5. PubMed ID: 12023790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pemetrexed: a promising new treatment for breast cancer.
    O'Shaughnessy JA; Gennari A; Conte P
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):36-41. PubMed ID: 12023791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pemetrexed: a novel antifolate agent enters clinical practice.
    Kut V; Patel JD; Argiris A
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):511-22. PubMed ID: 15270656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications.
    Chattopadhyay S; Moran RG; Goldman ID
    Mol Cancer Ther; 2007 Feb; 6(2):404-17. PubMed ID: 17308042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I trials of pemetrexed.
    Fossella FV; Gatzemeier U
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):8-16. PubMed ID: 12023787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology and mechanism of action of pemetrexed.
    Adjei AA
    Clin Lung Cancer; 2004 Apr; 5 Suppl 2():S51-5. PubMed ID: 15117425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folate status and the safety profile of antifolates.
    Calvert H
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):3-7. PubMed ID: 12023786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pemetrexed, an novel multitargeted antifolate: current development and future directions. Proceedings of a meeting. August 17-19, 2000. Colorado Springs, Colorado, USA.
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):1-61; quiz 62-9. PubMed ID: 12023785
    [No Abstract]   [Full Text] [Related]  

  • 37. Pemetrexed: an active new agent for breast cancer.
    O'Shaughnessy JA
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):57-62. PubMed ID: 12571813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Folate antagonist].
    Morikawa N
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():146-8. PubMed ID: 25831740
    [No Abstract]   [Full Text] [Related]  

  • 39. Pemetrexed as a single agent in the therapy of advanced lung cancer.
    Postmus PE; Bunn PA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):17-22. PubMed ID: 12023788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further study on pemetrexed based chemotherapy in treating patients with advanced gastric cancer (AGC).
    Liu J; Huang XE; Feng JF
    Asian Pac J Cancer Prev; 2014; 15(16):6587-90. PubMed ID: 25169492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.